Stock-based Compensation, Restricted Stock Awards Activity (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Ocuphire Restricted Stock Awards [Abstract] | ||||
Stock based compensation | $ 493,000 | $ 478,000 | $ 1,383,000 | $ 1,435,000 |
Ocuphire Restricted Stock Awards [Member] | ||||
Ocuphire Restricted Stock Awards [Abstract] | ||||
Granted (in shares) | 0 | 0 | ||
Vested (in shares) | 0 | (40,000) | ||
Forfeited (in shares) | 0 | 0 | ||
Stock based compensation | $ 0 | $ 22,000 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|